Do not change your dose or stop Ozempic, Wegovy, Mounjaro, or Zepbound without medical guidance, especially if you have diabetes, blood sugar concerns, or other medical conditions
This peptide may be particularly helpful for patients who feel chronically fatigued, recover poorly from exercise, or feel metabolically stuck despite following reasonable diet and movement patterns
Monitor Regulatory Developments: The GLP-1 space is evolving rapidly, and FDA may issue further clarifications or enforcement actions impacting both 503Bs and 503As
According to the authors, though, these latter studies have largely relied on self-reported surveys of GLP-1 users, which can be subject to several issues (people arent great at remembering even their recent meals, for one)